Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC): a multicentre, open-label, randomised, phase 2 trial
| Autor: | Vogel, Arndt *, Saborowski, Anna, Wenzel, Patrick, Wege, Henning, Folprecht, Gunnar, Kretzschmar, Albrecht, Schütt, Philipp, Jacobasch, Lutz, Ziegenhagen, Nicolas, Boeck, Stefan, Zhang, Danmei, Kanzler, Stephan, Belle, Sebastian, Mohm, Johannes, Gökkurt, Eray, Lerchenmüller, Christian, Graeven, Ullrich, Pink, Daniel, Götze, Thorsten, Kirstein, Martha M |
|---|---|
| Zdroj: | In The Lancet Gastroenterology & Hepatology August 2024 9(8):734-744 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|